EricHollanderMDFACNP, DFAPA

PubMed

• 249 citations
  Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
  Yechiel Levkovitz, Moshe Isserles, Frank Padberg, Sarah H. Lisanby, Alexander Bystritsky
  World Psychiatry. 2015-02-01
• 59 citations
  Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
  Michael R. Liebowitz, Jack M. Gorman, Abby J. Fyer, Raphael Campeas, Andrew P. Levin
  The Journal of Clinical Psychiatry. 1988-07-01
• 279 citations
  Phenelzine vs atenolol in social phobia: A placebo-controlled comparison.
  Michael R. Liebowitz, Frank Schneier, Raphael Campeas, Eric Hollander, Julie A. Hatterer
  Archives of General Psychiatry. 1992-04-01

Journal Articles

• In Search of Biomarkers for Autism Spectrum Disorder  
  Eric Hollander, James T McCracken, Autism Research
• Manifesto for a European research network into obsessive-compulsive and related disorders  
  Van Ameringen M, Simpson W, Patterson B, Dell'osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H,..., Eur Neuropsychopharmacol, 1/1/2013
• Guidelines for the pharmacological treatment of axiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care  
  Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Moller HJ, WFSBP Task Force on Mental Disorders in Primary Care; WPSBP Task Force on Anxiety Disorder..., Int J Psychiatry Clin Pract, 1/1/2012
• Low-frequnecy rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response,  
  Pallanti S, Di Rollo A, Antonini S, Cauli G, Hollander E, Quercioli L, Neuropsychobiology, 1/1/2012
• A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders  
  Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C, Am J Psychiatry, 1/1/2012
• Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders  
  Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A, J Autism Dev Disord, 1/1/2012
• A double-blind, placebo-controlled trial of topiramate for pathological gambling  
  Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E, World J Biol Psychiatry, 1/1/2011
• The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB  
  Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E, Psychiatry Res, 1/1/2011
• Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study (Erratum)  
  Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW, Br J Psychiatry, 1/1/2011
• In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism  
  Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J, Brain Res, 1/1/2011
• Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder  
  Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E, J Clin Psychiatry, 1/1/2011
• Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees  
  Hankin CS, Koran L, Sheehan DV, Hollander E, Culpepper L, Black DW, Knispel J, Dunn J, Dougherty DD, Bronstone A, Wang Z, Ann Clin Psychiatry, 1/1/2011
• Novel treatment options of binge eating disorder  
  Marazziti D, Rossi L, Baroni S, Consoli G, Hollander E, Catena-Dell'osso M, Curr Med Chem, 1/1/2011
• Development and validation of the appearance and performance enhancing drug use schedule  
  Hildebrandt T, Langenbucher JW, Lai JK, Loeb KL, Hollander E, Addict Behav, 1/1/2011
• Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment  
  Fineberg N, Chamberlain S, Hollander E, Boulougouris V, Robbins T, Br J Pharmecol, 1/1/2011
• Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study  
  Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E, Psychoneuroendocrinology, 1/1/2011
• Oxytocin can hinder trust and cooperation in borerline personality disorder  
  Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E, Soc Cogn Affect Neurosci, 1/1/2011
• Factor analysis of repetitive behaviors in Autism as measured by the Y-BOCS  
  Anagnostou E, Chaplin W, Watner D, Silverman JM, Smith CJ, Zagursky K, Kryzak LA, Corwin TE, Feirsen N, Tanel N, Hollander E, J Neuropsychiatry Clin Neurosci, Summer, 1/1/2011
• Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study  
  Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E, PLoS One, 1/1/2011
• Serotonin functionin pathological gambling: blunted growth hormone response to Sumatriptan  
  Pallanti S, Bernardi S, Allen A, Hollander E, J Psychopharmacol, 1/1/2010
• Probing compulsitve and impulsive behaviors, from animal models to endophenotypes: a narrative review  
  Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E, Neuropsychopharmacology, 1/1/2010
• Relationship between whole blood serotonin and repetitive behaviors in autism  
  Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH Jr, Silverman JM, Psychiatry Res, 1/1/2010
• Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder  
  Dell’Osso B, Buoli M, Hollander E, Altamura AC, World J Biol Psychiatry, 1/1/2010
• Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder  
  Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E, Compr Psychiatry, 1/1/2010
• Autism and oxytocin: new developments in translational approaches to therapeutics  
  Green JJ, Hollander E, Neurotherapeutics, 1/1/2010
• Join now to see all

Books/Book Chapters

• Autism Spectrum Disorders 
  Chapter: Comorbid Obsessive-Compulsive Disorders. 
  Page 270 - 284Taylor BP, HollanderOxford University Press2011
• Obsessive-Compulsive Spectrum Disorders: Refining the Research Agenda for DSM-V. 
  Editors: Hollander E, Zohar J, Sirovatka PJ, Regier DA.American Psychiatric Association, Arlington, VA2011
• Textbook of Autism Spectrum Disorders. 
  Hollander E, Kolevzon A, Coyle JAmerican Psychiatric Publishing, Inc., Washington, DC2010
• Textbook of Anxiety Disorders 
  Stein DJ, Hollander E, Rothbaum BAmerican Psychiatric Publishing, Inc., Washington, DCEdition 2nd,2009
• Advances In Vasopressin and Oxytocin—From Genes to Behaviour To Disease, Progress In Brain Research (Volume 170) 
  Chapter: Oxytocin and experimental therapeutics in autism spectrum disorders. 
  Page 451 - 462Bartz JA, Hollander EEditors: Neumann ID, Landgraf R.Elsevier, Oxford2008
• American Psychiatric Publishing Textbook of Psychiatry 
  Chapter: Anxiety disorders. 
  Page 505 - 607Hollander E, Simeon DAmerican Psychiatric Publishing, Washington, DCEdition 5th,2008
• The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences 
  Chapter: Neuropsychiatric aspects of aggression and impulse control disorders. 
  Page 535 - 565Hollander E, Berlin HAEditors: Yudofsky SC and Hales RE.American Psychiatric Publishing, Inc., Washington, DCEdition 5th,2008
• Handbook of Psychiatric Measures 
  Chapter: Impulse-control disorders measures. 
  Page 667 - 686Hollander E, Berlin HAEditors: Rush AJ, First MB, Blacker D.American Psychiatric Publishing, Inc, Artlington, VAEdition 2nd,2008
• American Psychiatric Publishing Textbook of Psychiatry 
  Chapter: Impulse control disorders not elsewhere classified. 
  Page 777 - 820Hollander E, Berlin, HA, Stein, DJAmerican Psychiatric Publishing, Washington, DCEdition 5th,2008
• Clinical Manual for the Treatment of Autism. 
  Editors: Hollander E, Anagnostou E.American Psychiatric Publishing, Inc., Washington, DC2007
• Clinical Manual of Impulse Control Disorders. 
  Chapter: Conceptualizing and assessing impulse-control disorders. 
  Page 1 - 18Hollander E, Baker BR, Kahn J, Stein DJEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
• Clinical Manual of Impulse Control Disorders. 
  Chapter: Sexual compulsions. 
  Page 87 - 114Allen A, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
• Clinical Manual of Impulse Control Disorders. 
  Chapter: Pathological gambling. 
  Page 251 - 289Pallanti S, Baldini Rossi N, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
• Clinical Manual of Impulse Control Disorders. 
  Chapter: Treatment of impulse-control disorders. 
  Page 309 - 325Stein DJ, Harvey B, Seedat S, Hollander EEditors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
• Textbook of Suicide Assessment and Management 
  Chapter: Anxiety disorders. 
  Page 313 - 332Simeon D, Hollander EEditors: Simon RI, Hales RE.American Psychiatric Publishing, Washington, DC2006
• Essentials of Clinical Psychopharmacology 
  Chapter: Treatment of Personality Disorders. 
  Page 689 - 705Simeon D, Hollander EEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Washington, DCEdition 2nd,2006
• Progress in Neurotherapeutics and Neuropsychopharmacology, Vol 1 
  Chapter: Liquid Fluoxetine versus placebo for repetitive behaviors in childhood autism. 
  Hollander E, Swanson E, Anagnostou E, Phillips A, Chaplin W, Wasserman SCambridge University Press, Cambridge, United Kingdom2006
• Clinical Manual of Impulse Control Disorders. 
  Editors: Hollander E, Stein DJ.American Psychiatric Publishing, Inc., Washington, DC2006
• Coping with Social Anxiety: The Definitive Guide to Effective Treatment Options. 
  Editors: Hollander E, Bakalar N.Henry Holt and Company, New York, NY2005
• Somatoform Disorders, Volume 9 
  Chapter: Advancing the understanding of dysmorphic disorder. 
  Hollander E, Dell’osso BEditors: Maj M, Akiskal HS, Mezzich J, Okasha A.Wiley Publishing, Inc., NJ2005
• Pathological Gambling: A Clinical Guide to Treatment 
  Chapter: Pharmacological Treatments. 
  Page 189 - 205Hollander E, Kaplan A, Pallanti SEditors: Grant JE, Potenza MN.American Psychiatric Publishing, Inc., Washington, DC2004
• Essentials of Clinical Psychiatry 
  Chapter: Anxiety disorders. 
  Page 339 - 422Hollander E, Simeon DEditors: Hales RE and Yudofsky SC.American Psychiatric Publishing, Arlington, VAEdition 2nd,2004
• American Psychiatric Publishing Textbook of Psychopharmacology 
  Chapter: Treatment of personality disorders. 
  Hollander E, Simeon DEditors: Schatzberg AF and Nemeroff CB.American Psychiatric Publishing, Inc., Arlington, VAEdition 3rd,2004
• Tratado de los Trastornos de Ansiedad. 
  Editors: Stein DJ, Hollander E.Ars Medica, Barcelona, Spain2004
• Autism Spectrum Disorders 
  Chapter: Core symptoms, related disorders, and course of autism. 
  Page 15 - 38Hollander E, Nowinski CVEditors: Hollander E.Marcel Dekker, Inc., New York, NY2003
• Join now to see all

Other

• Comorbid social anxiety disorder and body dysmorphic disorder. 
  Hadley SJ, Greenberg J, Hollander E, Anxiety and Depression (STAND)
  www.depression.org
  1/1/2002
• Insuring a sound financial future for the ACNP. 
  Hollander E, ACNP Bulletin